Nightmares in Strattera - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Nightmares, when it was recovered, drug effectiveness, race, and more among people who take Strattera (atomoxetine hydrochloride). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Nightmares?

Nightmares (unpleasant dreams) is found to be associated with 1,327 drugs and 1,914 conditions by eHealthMe. Check the latest studies of Nightmares.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jun, 15, 2026

7 people who have Nightmares while taking Strattera were studied.

Severity of Nightmares *:

least: 0.0 %
moderate: 33.33 %
severe: 66.67 %
most severe: 0.0 %

When people recovered from Nightmares *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Strattera *:

not at all: 0.0 %
somewhat: 40 %
moderate: 20 %
high: 40 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 16.67 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 83.33 %

Time on Strattera *:

Gender of people when taking Strattera *:

female: 85.71 %
male: 14.29 %

Age of people when taking Strattera *:

Conditions people have *:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 28.57%
Stress And Anxiety: 1 person, 14.29%
Psychosis: 1 person, 14.29%
Primary Insomnia (sleep disorder): 1 person, 14.29%
Premenstrual Dysphoric Disorder: 1 person, 14.29%
Post-Traumatic Stress Disorder: 1 person, 14.29%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 1 person, 14.29%
Personality Disorder: 1 person, 14.29%
Panic Disorder Without Agoraphobia (panic disorder without anxiety disorder): 1 person, 14.29%
Nutritional Condition Abnormal: 1 person, 14.29%

Other drugs people take besides Strattera *:

Other side effects people have besides Nightmares *:

Sweating: 2 people, 28.57%
Irritability: 2 people, 28.57%
Weight Loss: 1 person, 14.29%
Flatulence (flatus expelled through the anus): 1 person, 14.29%
Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 1 person, 14.29%
Constipation: 1 person, 14.29%
Dehydration (dryness resulting from the removal of water): 1 person, 14.29%
Dry Mouth: 1 person, 14.29%
Ear Barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum): 1 person, 14.29%
Fatigue (feeling of tiredness): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Nightmares?

Check whether Nightmares is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Nightmares in Strattera

How the study uses the data?

The study is based on atomoxetine hydrochloride (the active ingredients of Strattera). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.